EXERCISE FOR METASTATIC CASTRATE-RESISTANT PROSTATE CANCER: A FEASIBILITY TRIAL IN PROGRESS DURING THE COVID-19 PANDEMIC (EXACT)
Supportive Care in Cancer
; 30:S41, 2022.
Article
in English
| EMBASE | ID: covidwho-1935781
ABSTRACT
Introduction A global trial is currently investigating the impact of high-intensity interval training (HIIT) on survival in advanced prostate cancer (the INTERVAL trial). To ensure greater accessibility, we designed a parallel trial (EXACT), to determine the feasibility of exercise in those contraindicated to HIIT. Methods Men with metastatic castrate-resistant prostate cancer being actively treated with androgen deprivation therapy and a novel hormone therapy (abiraterone acetate or enzalutamide) are eligible to participate in 12- weeks of home-based walking and strengthening. Participants complete physical (e.g. 6-min walk test and timed sit-to-stand) and quality of life (e.g. BPI-SF;EQ-5D-5L;FACIT-fatigue;FACT-P) outcomes at baseline (T1), 12 (T2) and 24 weeks (T3). This trial was adapted to enable remote recruitment and delivery during the COVID-19 pandemic. Results To date, 118 patients have been screened, with 33 approached by their clinician to participate. 25 patients have consented, with 12 completing the trial without any intervention-related adverse events and 6 withdrawn. Recruitment and trial delivery was operational throughout the COVID-19 pandemic. Currently positive trends are evident for physical and quality of life outcomes at T2 and T3. Conclusions Although this trial is ongoing, early trends suggest this intervention is safe and feasible for men with advanced castration resistant prostate cancer and could improve physical capacity and quality of life.
adult; advanced cancer; castration resistant prostate cancer; clinical trial; conference abstract; controlled study; coronavirus disease 2019; drug withdrawal; European Quality of Life 5 Dimensions 5 Level questionnaire; exercise; feasibility study; Functional Assessment of Cancer Therapy Prostate; Functional Assessment of Chronic Illness Therapy Fatigue Scale; human; major clinical study; male; metastatic castration resistant prostate cancer; pandemic; physical capacity; quality of life; six minute walk test
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Type of study:
Randomized controlled trials
Language:
English
Journal:
Supportive Care in Cancer
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS